Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced multiple oral and poster presentations, ...

Ovarian cancer continues to pose a significant challenge in the medical field, remaining one of the leading causes of death ...

Recent research has shown that most, if not all, high grade serous ovarian cancers originate in the fallopian tubes. With no pronounced symptoms or tests to catch it early, ovarian cancer is usually ...

After an extremely challenging period, Sandor and Erika Nagy have said they are "determined to keep living, creating and ...

Despite the physical and mental battles, and constant medical appointments, Sandor, 44, and Erika, 54, say they are ...

ASCO Guidelines follow the ASCO Conflict of Interest Policy for Clinical Practice Guidelines. To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery ...

Treatment for ovarian cancer might have taken her singing voice, but Ballarat musician and composer Mary Doumany has found a ...

胃癌转移方式多样，其中卵巢转移相对少见。研究表明，卵巢转移在女性胃癌患者中发生率约为 9.7%，且患者年龄相较未发生卵巢转移的患者普遍更小[1]。胃癌的卵巢转移通常表明病情已发展至晚期，对患者的预后和生活质量产生严重影响，治疗上存在较大困难，治疗手段探索尤为重要。今天我们就一起来学习胃癌卵巢转移。 PART 01 ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Preparations for pivotal-stage readiness of vididencel in AML on trackThe hard work of the Mendus team to advance the company's lead product vididencel in acute myeloid leukemia (AML) continued to pay ...

ovarian cancer progressing under taxane/carboplatin chemotherapy or in early relapse (< 6 months).

H. Ma and S. Srivastava are joint first authors of this article. R. Sundar and P. Tan are joint corresponding and senior authors of this article.